JKHY vs ORMP · P/E 30, rev $2.38B vs rev $1.3M
Jack Henry & Associates Inc (JKHY) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Jack Henry & Associates Inc (JKHY) is a information technology services company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported JKHY revenue for 2025-06-30 was $2.38B. Net income was $455.7M. Revenue was up 7.2% from 2024-06-30 to 2025-06-30. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
JKHY currently screens at market cap $12.76B and trailing P/E 29.8. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the JKHY and ORMP stock pages for the full models.
Not investment advice.